BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cabrera-Marante O, Rodríguez de Frías E, Serrano M, Lozano Morillo F, Naranjo L, Gil-Etayo FJ, Paz-Artal E, Pleguezuelo DE, Serrano A. The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome. Int J Mol Sci 2020;21:E8972. [PMID: 33255963 DOI: 10.3390/ijms21238972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Gil-Etayo FJ, Garcinuño S, Lalueza A, Díaz-Simón R, García-Reyne A, Pleguezuelo DE, Cabrera-Marante O, Rodriguez-Frias EA, Perez-Rivilla A, Serrano M, Serrano A. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines 2021;9:899. [PMID: 34440103 DOI: 10.3390/biomedicines9080899] [Reference Citation Analysis]
2 Mahroum N, Elsalti A, Alwani A, Seida I, Alrais M, Seida R, Esirgun SN, Abali T, Kiyak Z, Zoubi M, Shoenfeld Y. The mosaic of autoimmunity - Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens. Autoimmun Rev 2022;:103166. [PMID: 35932955 DOI: 10.1016/j.autrev.2022.103166] [Reference Citation Analysis]
3 Melayah S, Ghozzi M, Mankaï A, Mechi F, Ghedira I. Frequency of serological markers of rheumatoid arthritis in patients with IgA anti-β2 glycoprotein I antibodies. J Clin Lab Anal 2022;:e24537. [PMID: 35666694 DOI: 10.1002/jcla.24537] [Reference Citation Analysis]
4 Capozzi A, Riitano G, Mancuso S, Recalchi S, Manganelli V, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Truglia S, Sorice M. Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for 'seronegative' diagnosis. Clin Exp Immunol 2021;205:326-32. [PMID: 34107056 DOI: 10.1111/cei.13633] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Naranjo L, Ostos F, Gil-Etayo FJ, Hernández-Gallego J, Cabrera-Marante Ó, Pleguezuelo DE, Díaz-Simón R, Cerro M, Lora D, Martínez-Salio A, Serrano A. Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke. Front Cardiovasc Med 2021;8:665741. [PMID: 34012984 DOI: 10.3389/fcvm.2021.665741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Man YL, Sanna G. Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review. Brain Sciences 2022;12:91. [DOI: 10.3390/brainsci12010091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]